Back to Journals » Therapeutics and Clinical Risk Management » Volume 2 » Issue 1
Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
4,966 | Dovepress* | 4,966+ | 1,421 | 6,387 | |
Totals | 4,966 | 1,421 | 6,387 | ||
*Since 15 March 2006 +Since July 2016 |
View citations on Google Scholar